Zinlirvimab
Chemical
FDA Substance Registry (openFDA)
Learn more about this substance:
Ask ChatGPT
Google
PubChem
Wikipedia
EWG Skin Deep
INCIDecoder
ECHA
Chemical Identification
| CAS Number | 2417213-75-1 |
|---|
Known Aliases (6)
Common Name
10-1074
ANTI-HIV-1 HUMAN MONOCLONAL ANTIBODY TARGETING V3 GLYCAN SUPERSITE ON THE HIV-1 ENVELOPE PROTEIN (10-1074)
IMMUNOGLOBULIN G1 (443-LEUCINE,449-SERINE), ANTI-(HUMAN IMMUNODEFICIENCY VIRUS 1 ENVELOPE PROTEIN GP120ENV) (HUMAN MONOCLONAL 2G2-55D10 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL 2G2-55D10 .LAMBDA.-CHAIN, DIMER
zinlirvimab [INN]
ZINLIRVIMAB [USAN]
Zinlirvimab [WHO-DD]
Data Sources (1)
| Source | Source ID | Name in Source | Properties |
|---|---|---|---|
| FDA Substance Registry (openFDA) | L98LJF15I9 |
Zinlirvimab |
CAS: 2417213-75-1 INN: 11879 USAN: LM-84 SMS_ID: 300000042060 FDA UNII: L98LJF15I9 NCI_THESAURUS: C188593 |
Record Info
| ID | PQEgCAJzwrV4WQxZRbqPiF |
|---|---|
| Created | April 10, 2026, 8:05 p.m. |
| Modified | April 11, 2026, 12:24 a.m. |
| Data Source | FDA Substance Registry (openFDA) |